Skip to main content

ExonHit Gets $553K Grant for Participation in RESPONSIFY Project

NEW YORK (GenomeWeb News) – ExonHit today said that it will receive a €418,000 ($553,000) grant from the European Union for its participation in the recently announced RESPONSIFY consortium.

The Paris-based firm said that it will provide its Genome Wide SpliceArray platform for analysis of patient transcriptomic profiles. The company added that it will be in charge of filing for IP protection for relevant molecular signatures and associated tests and ensuring CE marking and commercialization of predictive tests identified on the platform.

The RESPONSIFY consortium was recently launched with the aim of developing tests to indicate how therapies will affect individual patients and enable doctors to make better decisions about whether to use neoadjuvant therapies or provide treatments after surgery. The partners intend to identify predictive biomarkers for response to two common chemotherapeutic treatments for breast cancer, Herceptin (trastuzumab) and Avastin (bevacizumab).

The three-year project will include partners in Belgium, France, Germany, Sweden, Switzerland, and the UK, and is being funded with approximately €6 million under the EU's 7th Framework Programme for Research and Technological Development.

"This grant, which covers more than 70 percent of our costs in this project, enables us to add predictive tests in a key indication to our existing development portfolio," Loic Maurel, president of Exonhit's management board, said in a statement.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.